Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Buy
4,153
+121
+3% +$43.1K 0.05% 130
2025
Q4
$1.32M Buy
4,032
+163
+4% +$51.7K 0.05% 131
2025
Q3
$1.09M Buy
3,869
+206
+6% +$59.7K 0.04% 155
2025
Q2
$1.02M Sell
3,663
-346
-9% -$98K 0.05% 151
2025
Q1
$1.25M Buy
4,009
+117
+3% +$34.5K 0.06% 126
2024
Q4
$1.01M Buy
3,892
+39
+1% +$11.6K 0.05% 149
2024
Q3
$1.24M Sell
3,853
-250
-6% -$81.8K 0.06% 128
2024
Q2
$1.28M Buy
+4,103
New +$1.21M 0.07% 114

Other funds holding AMGN

Aviso Financial's AMGN Position: Q1 2026 in Review

Aviso Financial increased its Amgen (AMGN) stake by 3% in Q1 2026, buying an estimated $43.1K and bringing the position to 4,153 shares worth $1.46M. The position accounts for 0.05% of the portfolio, ranked #130.

Aviso Financial first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Aviso Financial held 4,153 shares of Amgen worth $1.46M as of Q1 2026.
  • Aviso Financial bought 121 Amgen shares in Q1 2026, an estimated $43.1K.
  • Amgen made up 0.05% of Aviso Financial's portfolio in Q1 2026, its #130 holding.
  • Aviso Financial first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.